메뉴 건너뛰기




Volumn 10, Issue 3, 2006, Pages 159-164

Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy

Author keywords

Bezafibrate; HAART; HIV; Hypertriglyceridemia

Indexed keywords

ANTIRETROVIRUS AGENT; BEZAFIBRATE; CD4 ANTIGEN; CD8 ANTIGEN; CEDURA RETARD; CREATINE KINASE; LIVER ENZYME; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL;

EID: 33749079204     PISSN: 14138670     EISSN: 14138670     Source Type: Journal    
DOI: 10.1590/S1413-86702006000300001     Document Type: Article
Times cited : (4)

References (52)
  • 2
    • 2642709177 scopus 로고    scopus 로고
    • Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
    • Patella Jr F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N EngI J Med 1998;338(13):853-60.
    • (1998) N EngI J Med , vol.338 , Issue.13 , pp. 853-860
    • Patella Jr., F.J.1    Delaney, K.M.2    Moorman, A.C.3
  • 3
    • 0032558814 scopus 로고    scopus 로고
    • Protease inhibitor - Associated hyperinsulinaemia
    • Martinez R., Casamitjana I., Gatell J.M. Protease inhibitor - associated hyperinsulinaemia. AIDS 1998; 12(15):2077-9.
    • (1998) AIDS , vol.12 , Issue.15 , pp. 2077-2079
    • Martinez, R.1    Casamitjana, I.2    Gatell, J.M.3
  • 4
    • 0030926042 scopus 로고    scopus 로고
    • Marked hyperlipidaemia on ritonavir therapy
    • Sullivan A.K., Nelson M.R. Marked hyperlipidaemia on ritonavir therapy. AIDS 1997; 11(7); 93 8-9.
    • (1997) AIDS , vol.11 , Issue.7 , pp. 938-939
    • Sullivan, A.K.1    Nelson, M.R.2
  • 5
    • 0032537042 scopus 로고    scopus 로고
    • Indinavir - Associated Lipodystrophy
    • Viraben R., Christian A. Indinavir - Associated Lipodystrophy. AIDS 1998;12:F13-39.
    • (1998) AIDS , vol.12
    • Viraben, R.1    Christian, A.2
  • 6
    • 0032551258 scopus 로고    scopus 로고
    • Pathogenesis of HIV-1 - Protease inhibitor - Associated peripheral lipodystrophy, hyperlipidaemia and insulin resistance
    • 351
    • Carr A., Samaras K., Chisholm D.J., Cooper D.A. Pathogenesis of HIV-1 - protease inhibitor - associated peripheral lipodystrophy, hyperlipidaemia and insulin resistance. Lancet 1998 b;20; 351(9119):1881-3.
    • (1998) Lancet , vol.20 , Issue.9119 , pp. 1881-1883
    • Carr, A.1    Samaras, K.2    Chisholm, D.J.3    Cooper, D.A.4
  • 7
    • 0032493043 scopus 로고    scopus 로고
    • A syndrome of peripheral lipodistrophy, hyperlipidaemia and insulin resistence in patients receiving HIV protease inhibitors
    • Carr A., Samaras K., Burton S., Law M., Freund J., Chisholm D.J. et al. A syndrome of peripheral lipodistrophy, hyperlipidaemia and insulin resistence in patients receiving HIV protease inhibitors. AIDS 1998a; 12:F51-8.
    • (1998) AIDS , vol.12
    • Carr, A.1    Samaras, K.2    Burton, S.3    Law, M.4    Freund, J.5    Chisholm, D.J.6
  • 8
    • 0025872834 scopus 로고
    • Circulating interferon-a levels and hypertriglyderidemia in the Acquired Immunodeficiency Syndrome
    • Grunfeld C., Kotler D.P., Shigenaga J.K., et al. Circulating interferon-a levels and hypertriglyderidemia in the Acquired Immunodeficiency Syndrome. Am J Med 1991;90:154-62.
    • (1991) Am J Med , vol.90 , pp. 154-162
    • Grunfeld, C.1    Kotler, D.P.2    Shigenaga, J.K.3
  • 9
    • 0032493043 scopus 로고    scopus 로고
    • A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistence in patients HIV receiving protease inhibitors
    • Caar A., Samaras K., Burton S., et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistence in patients HIV receiving protease inhibitors. AIDS 1998a; 12(7):F51-58.
    • (1998) AIDS , vol.12 , Issue.7
    • Caar, A.1    Samaras, K.2    Burton, S.3
  • 10
    • 0024497306 scopus 로고
    • Hypertriglyceridemia in the Acquired Immunodeficiency Syndrome
    • Grunfield C., Kotler D.P., Hamadeh R., et al. Hypertriglyceridemia in the Acquired Immunodeficiency Syndrome. Am J Med 1989;86:27-31.
    • (1989) Am J Med , vol.86 , pp. 27-31
    • Grunfield, C.1    Kotler, D.P.2    Hamadeh, R.3
  • 11
    • 33749076097 scopus 로고    scopus 로고
    • Update on lipid abnormalities and cardiovascular complications in HIV infection
    • In: (San Diego), San Diego
    • Kotler D.P. Update on lipid abnormalities and cardiovascular complications in HIV infection. In: Program and abstracts: XXXVIII Satellite Symposium ICAAC (San Diego), San Diego, 1998.
    • (1998) Program and Abstracts: XXXVIII Satellite Symposium ICAAC
    • Kotler, D.P.1
  • 12
    • 0024446834 scopus 로고
    • Magnitude of body- cell-mass depletion and the timing of death from wasting in aids
    • Kotler D.P., Tierney A.R., Wang J., Pierson Jr R.N. Magnitude of body- cell-mass depletion and the timing of death from wasting in aids. Am J Clin Nutr 1989;50:444-7.
    • (1989) Am J Clin Nutr , vol.50 , pp. 444-447
    • Kotler, D.P.1    Tierney, A.R.2    Wang, J.3    Pierson Jr., R.N.4
  • 13
    • 0023232216 scopus 로고
    • Helsinki heart study: Primary prevention trial with genifibrozil in middle-age men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary artery disease
    • Frick M.H., Elo O., Haapa K., et al. Helsinki heart study: primary prevention trial with genifibrozil in middle-age men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary artery disease. N Engl J Med 1987;317(20):1237-45.
    • (1987) N Engl J Med , vol.317 , Issue.20 , pp. 1237-1245
    • Frick, M.H.1    Elo, O.2    Haapa, K.3
  • 14
    • 0033583977 scopus 로고    scopus 로고
    • Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
    • Carr A., Samaras K., Thorisdottir A., et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093-9.
    • (1999) Lancet , vol.353 , pp. 2093-2099
    • Carr, A.1    Samaras, K.2    Thorisdottir, A.3
  • 15
    • 0032572211 scopus 로고    scopus 로고
    • Vascular complications associated with use of HIV protease inhibitors
    • Gallet B., Pulik M., Genet P., et al. Vascular complications associated with use of HIV protease inhibitors. Lancet 1998;351:1958-60.
    • (1998) Lancet , vol.351 , pp. 1958-1960
    • Gallet, B.1    Pulik, M.2    Genet, P.3
  • 16
    • 17144463863 scopus 로고    scopus 로고
    • Severe premature coronary artery disease with protease inhibitor
    • [letter]
    • Henry K., Melore H., Huebsch J., et al. Severe premature coronary artery disease with protease inhibitor [letter]. Lancet 1998;351(9112):1328.
    • (1998) Lancet , vol.351 , Issue.9112 , pp. 1328
    • Henry, K.1    Melore, H.2    Huebsch, J.3
  • 19
    • 0031867939 scopus 로고    scopus 로고
    • Baffling case of bulging belly. Protease punch
    • Mishriki Y.Y. Baffling case of bulging belly. Protease punch. Postgrad Med 1998; 104(3):45-6.
    • (1998) Postgrad Med , vol.104 , Issue.3 , pp. 45-46
    • Mishriki, Y.Y.1
  • 21
    • 0033545441 scopus 로고    scopus 로고
    • Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
    • Gervasoni C., Ridolfo A.L., Trifiro G., et al. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS 1999; 13(4):465-71.
    • (1999) AIDS , vol.13 , Issue.4 , pp. 465-471
    • Gervasoni, C.1    Ridolfo, A.L.2    Trifiro, G.3
  • 23
    • 0035194391 scopus 로고    scopus 로고
    • Cardivascular disease risk factors in HIV-infected patients in the HAART Era
    • Galli M., Ridolfo A.L., Gervasoni C. Cardivascular disease risk factors in HIV-infected patients in the HAART Era. Ann NY Acad Sci 2001;946:200-13.
    • (2001) Ann NY Acad Sci , vol.946 , pp. 200-213
    • Galli, M.1    Ridolfo, A.L.2    Gervasoni, C.3
  • 24
    • 1642390559 scopus 로고    scopus 로고
    • III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Atersclerose da Sociedade Brasileira de Cardiologia
    • III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Atersclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2001;77(S III).
    • (2001) Arq Bras Cardiol , vol.77 , Issue.SIII
  • 25
    • 0034457426 scopus 로고    scopus 로고
    • Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of adult aids clinical trial group cardiovascular disease focus group
    • Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
    • Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of adult aids clinical trial group cardiovascular disease focus group. Clin Infect Dis 2000;31:1216-24.
    • (2000) Clin Infect Dis , vol.31 , pp. 1216-1224
  • 26
    • 0010979681 scopus 로고    scopus 로고
    • Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • National Cholesterol Education Program
    • National Cholesterol Education Program. Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;10:299-313.
    • (2001) JAMA , vol.10 , pp. 299-313
  • 27
    • 0032569488 scopus 로고    scopus 로고
    • Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities
    • Henry K., Huebesch J., Hermundson J., Simpson J. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet 1998;352:1031-2.
    • (1998) Lancet , vol.352 , pp. 1031-1032
    • Henry, K.1    Huebesch, J.2    Hermundson, J.3    Simpson, J.4
  • 28
    • 33749065194 scopus 로고    scopus 로고
    • Abordagem prática do manuseio das dislipidemias associadas à infecção pelo HIV e seu tratamento
    • Santos D.S. Abordagem prática do manuseio das dislipidemias associadas à infecção pelo HIV e seu tratamento. BJID 2004;8:22-36.
    • (2004) BJID , vol.8 , pp. 22-36
    • Santos, D.S.1
  • 29
    • 0029982038 scopus 로고    scopus 로고
    • Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
    • Ericsson C.G, Hamsten A., Nilsson J., Grip L., Svane B., de Faire U. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 1996;347:849-53.
    • (1996) Lancet , vol.347 , pp. 849-853
    • Ericsson, C.G.1    Hamsten, A.2    Nilsson, J.3    Grip, L.4    Svane, B.5    de Faire, U.6
  • 30
    • 0004318660 scopus 로고    scopus 로고
    • Obesity: Preventing and managing the global epidemic of obesity
    • World Health Organization. In: Geneva, 3-5 june
    • World Health Organization. Obesity: preventing and managing the global epidemic of obesity. In: Report of the WHO consultation of obesity. Geneva, 3-5 june, 1997.
    • (1997) Report of the WHO Consultation of Obesity
  • 31
    • 0038301516 scopus 로고    scopus 로고
    • Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
    • Calza L., Manfredi R., Chiodo F. Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART. AIDS 2003;14:851-9.
    • (2003) AIDS , vol.14 , pp. 851-859
    • Calza, L.1    Manfredi, R.2    Chiodo, F.3
  • 32
    • 13244249850 scopus 로고    scopus 로고
    • Managing cardiovascular risk in patients with HIV infection
    • Stein J.H. Managing cardiovascular risk in patients with HIV infection. J Acquir Immune Defic Syndr 2005;38:115-23.
    • (2005) J Acquir Immune Defic Syndr , vol.38 , pp. 115-123
    • Stein, J.H.1
  • 33
    • 19644395095 scopus 로고    scopus 로고
    • Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active therapy regimens in Western India
    • Sanjay N.P., Dravid A., Naik E., et al. Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active therapy regimens in Western India. J Acquir Immune Defic Syndr 2005;39:199-202.
    • (2005) J Acquir Immune Defic Syndr , vol.39 , pp. 199-202
    • Sanjay, N.P.1    Dravid, A.2    Naik, E.3
  • 34
    • 17844382195 scopus 로고    scopus 로고
    • Cardiovascular disease in HIV-positive patients
    • Kamin D.S., Grinspoon S.K. Cardiovascular disease in HIV-positive patients. AIDS 2005;19:641-52.
    • (2005) AIDS , vol.19 , pp. 641-652
    • Kamin, D.S.1    Grinspoon, S.K.2
  • 35
    • 18144389038 scopus 로고    scopus 로고
    • Increased cardiovascular disease risk indices in HIV-infected women
    • Dolan S.E., Hadigan C., Killilea K.M., et al. Increased cardiovascular disease risk indices in HIV-infected women. J Acquir Immune Defic Syndr 2005;39:44-54.
    • (2005) J Acquir Immune Defic Syndr , vol.39 , pp. 44-54
    • Dolan, S.E.1    Hadigan, C.2    Killilea, K.M.3
  • 36
    • 33749056708 scopus 로고    scopus 로고
    • Epidemiologia das doenças cardiovasculares (DCV): Dados do Brasil
    • Curso de Reciclagem em Cardiologia da Sociedade de Cardiologia do RS/SBC
    • Achutt A. Epidemiologia das doenças cardiovasculares (DCV): Dados do Brasil. Curso de Reciclagem em Cardiologia da Sociedade de Cardiologia do RS/SBC, 2003. www.cardiol.com.br
    • (2003)
    • Achutt, A.1
  • 37
    • 0009657925 scopus 로고    scopus 로고
    • Aids: O mapa ecológico do Brasil 1982-1994
    • In: Brasilia: Ministério da Saúde. Coordenação Nacional de DST e Aids. Ministério da Saúde Brasília
    • Szwarcwald C.L., Bastos F.I., Andrade C.L.T., Castilho E.A. Aids: o mapa ecológico do Brasil 1982-1994. In: A epidemia da aids no Brasil: situação e tendências. Brasilia: Ministério da Saúde. Coordenação Nacional de DST e Aids. Ministério da Saúde Brasília 1997; p.27-44.
    • (1997) A Epidemia Da Aids No Brasil: Situação E Tendências , pp. 27-44
    • Szwarcwald, C.L.1    Bastos, F.I.2    Andrade, C.L.T.3    Castilho, E.A.4
  • 38
    • 33749066210 scopus 로고    scopus 로고
    • Boletim epidemiológico. AIDS ANO XVII no 01. 01 a 52 Semanas epidemiológicas janeiro a dezembro de Available from
    • Boletim epidemiológico. AIDS ANO XVII no 01. 01 a 52 Semanas epidemiológicas janeiro a dezembro de 2003. Available from: http://www.Aids.gov.br/final/dados/bol_aids1.htm
    • (2003)
  • 40
    • 0032797624 scopus 로고    scopus 로고
    • Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
    • Behrens G, Dejam A., Schmidt H., et al. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 1999;13:F63-70.
    • (1999) AIDS , vol.13
    • Behrens, G.1    Dejam, A.2    Schmidt, H.3
  • 41
    • 0032831091 scopus 로고    scopus 로고
    • Lipid evaluation in HIV-1-positive patients treated with protease inhibitors
    • Schmidt H.H., Behrens G., Genschel J., et al. Lipid evaluation in HIV-1-positive patients treated with protease inhibitors. Antivir Ther 1999;4:163-70.
    • (1999) Antivir Ther , vol.4 , pp. 163-170
    • Schmidt, H.H.1    Behrens, G.2    Genschel, J.3
  • 42
    • 0034699898 scopus 로고    scopus 로고
    • Adverse effects of antiretroviral therapy
    • Carr A., Cooper D. Adverse effects of antiretroviral therapy. Lancet 2000;356:1423-30.
    • (2000) Lancet , vol.356 , pp. 1423-1430
    • Carr, A.1    Cooper, D.2
  • 43
    • 0033873920 scopus 로고    scopus 로고
    • Hyperlipidemia associated with HIV protease inhibitor use: Pathophysiology, prevalence, risk factors and treatment
    • Penzak S.R., Chuck S.K. Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment. Scand J Infect Dis 2000;32:111-23.
    • (2000) Scand J Infect Dis , vol.32 , pp. 111-123
    • Penzak, S.R.1    Chuck, S.K.2
  • 44
    • 0345620788 scopus 로고    scopus 로고
    • Hypertriglyceridemia: Changes in the plasma lioproteins associated with an increased risk of cardiovascular disease
    • Brewer H.B. Hypertriglyceridemia: changes in the plasma lioproteins associated with an increased risk of cardiovascular disease. Am J Cardiol 1999;83:3F-12.
    • (1999) Am J Cardiol , vol.83
    • Brewer, H.B.1
  • 45
    • 0038301516 scopus 로고    scopus 로고
    • Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
    • Calza L., Manfredi R., Chiodo F. Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART. AIDS 2003;17:851-9.
    • (2003) AIDS , vol.17 , pp. 851-859
    • Calza, L.1    Manfredi, R.2    Chiodo, F.3
  • 46
    • 0034334027 scopus 로고    scopus 로고
    • Management of dyslipidemia in patients with HIV disease
    • Manfredi R. Management of dyslipidemia in patients with HIV disease. Clin Microbiol Infect 2000;6:579-84.
    • (2000) Clin Microbiol Infect , vol.6 , pp. 579-584
    • Manfredi, R.1
  • 47
    • 0012570692 scopus 로고    scopus 로고
    • Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study
    • Saint-Marc T., Partisani M., Poizot-Martin I., et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 2000;14:37-49.
    • (2000) AIDS , vol.14 , pp. 37-49
    • Saint-Marc, T.1    Partisani, M.2    Poizot-Martin, I.3
  • 48
    • 0002757941 scopus 로고    scopus 로고
    • Lipid elevations during non-nucleoside RTI (NNRTI) therapy: A cross-sectional analysis
    • Moyle G.J., Baldwin C. Lipid elevations during non-nucleoside RTI (NNRTI) therapy: a cross-sectional analysis. Antivir Ther 1999;4(Suppl 2):54.
    • (1999) Antivir Ther , vol.4 , Issue.SUPPL. 2 , pp. 54
    • Moyle, G.J.1    Baldwin, C.2
  • 49
    • 0032581590 scopus 로고    scopus 로고
    • Marked hypertriglyceridemia associated with ritonavir therapy
    • Sullivan A.K., Feher M.D., Nelson M.R., Gazzard B.G. Marked hypertriglyceridemia associated with ritonavir therapy. AIDS 1998;12:1393-4.
    • (1998) AIDS , vol.12 , pp. 1393-1394
    • Sullivan, A.K.1    Feher, M.D.2    Nelson, M.R.3    Gazzard, B.G.4
  • 50
    • 0036799835 scopus 로고    scopus 로고
    • Letters to the editor: Efficacy and safety of fenofibrate for the treatment of hypertriglyceridemia associated with antiretroviral therapy
    • Palacios R., Santos J., González M., Ruiz J. Letters to the editor: Efficacy and safety of fenofibrate for the treatment of hypertriglyceridemia associated with antiretroviral therapy. J AIDS 2002;31:251-2.
    • (2002) J AIDS , vol.31 , pp. 251-252
    • Palacios, R.1    Santos, J.2    González, M.3    Ruiz, J.4
  • 51
    • 0033972441 scopus 로고    scopus 로고
    • Pharmacokinetic-pharmacodynamic consequences and clinic relevance of cytochrome p450 3A4 inhibition
    • Dresser G.K., Spence J.D., Bailey D.G. Pharmacokinetic-pharmacodynamic consequences and clinic relevance of cytochrome p450 3A4 inhibition. Clin Pharmacokinet 2000;38:41-57.
    • (2000) Clin Pharmacokinet , vol.38 , pp. 41-57
    • Dresser, G.K.1    Spence, J.D.2    Bailey, D.G.3
  • 52
    • 0035853365 scopus 로고    scopus 로고
    • Rhabdomyolisis after cerivatatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidaemia
    • Mastroianni C.M., d'Ettorre G., Forcina G., et al. Rhabdomyolisis after cerivatatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidaemia. AIDS 2001;15:820-1.
    • (2001) AIDS , vol.15 , pp. 820-821
    • Mastroianni, C.M.1    d'Ettorre, G.2    Forcina, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.